Ardent Health Partners (NYSE:ARDT) Price Target Lowered to $21.00 at Truist Financial

Ardent Health Partners (NYSE:ARDT) had its price target trimmed by Truist Financial from $22.00 to $21.00 in a report published on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts have also recently issued reports about the company. Leerink Partners boosted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. restated a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Royal Bank of Canada restated an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Bank of America cut shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, KeyCorp initiated coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price for the company. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $22.00.

Ardent Health Partners Stock Performance

Ardent Health Partners stock opened at $15.86 on Monday. The business has a 50-day simple moving average of $16.71. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. Ardent Health Partners has a twelve month low of $14.57 and a twelve month high of $20.72.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Oliver Luxxe Assets LLC purchased a new stake in shares of Ardent Health Partners in the 4th quarter worth $1,465,000. JPMorgan Chase & Co. bought a new position in Ardent Health Partners during the 3rd quarter worth about $154,000. Franklin Resources Inc. purchased a new position in Ardent Health Partners during the 3rd quarter valued at about $15,839,000. Barclays PLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $385,000. Finally, Geode Capital Management LLC purchased a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $2,581,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.